GlassScriptPhysician profile
Amin Shams Soolari
NPI 1750995353
$1,406.17
in general payments reported to CMS, 2019-2025
9 companies · $672 in 2025
The $672 reported for 2025 was more than what 93% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $354 · 2023: $152 · 2024: $125 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $596 · Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $596.00 |
| Food and Beverage | $353.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geistlich Pharma, North America, INC. | $672.41 | 2025 | Vallos, No Product, Biomaterials |
| Implant Direct Sybron International LLC | $274.83 | 2022 | |
| Nobel Biocare USA | $127.05 | 2023 | Nobelactive |
| Zimvie INC. | $111.33 | 2024 | |
| Biohorizons Implant Systems INC. | $103.35 | 2021 | |
| Kerr Corporation | $45.07 | 2022 | |
| Dental Imaging Technologies Corp. | $33.80 | 2022 | |
| Dentsply Sirona INC | $24.62 | 2023 | Nupro |
| Southern Implants North America INC | $13.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amin Soolari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.